 |
|
|
|
|
|
|
|
 |
|
||||||
 |
 |
 |
|
||||
 |
|
||||||
 |
 |
 |
|
||||
 |
|
||||||
 |
|
||||||
 |
|
||||||
 |
|
||||||
 |
|
||||||
 |
|
||||||
 |
|
||||||
 |
|
||||||
 |
|
||||||
 |
|
||||||
 |
|
||||||
 |
|
||||||
 |
|
||||||
 |
 |
 |
|
||||
 |
|
||||||
| |
| President: |
Tadaharu Wakabayashi , MBA Formerly President of SmithKline Beecham Seiyaku And Vice President of SB in charge of Japan |
| General Affairs: |
Junko Nishioka, BS. AA Graduated from Hosei University and Pasadena City College |
| Senior Consultant: |
Masao Hayashi, Pharmacist Formerly Corporate Officer at Aventis Pharma, Director of Clinical Research (Board Member) at Nippon Roussel Co., Ltd. |
| Associate: |
Naoharu Watanabe Ph. D (Science) Formerly TMRC Co., Ltd. |
| Medical Advisor: |
Ryutaro Takahashi, MDAPh.D. Director, Department of Nursing and Health Care Tokyo Metropolitan Institute of Gerontology |